About

Thing
Cofactor will automatically discover the description of this topic and display it here.

Mentions

Discovered and developed by AbbVie, RINVOQ is a selective and reversible JAK inhibitor studied in several immune-mediated inflammatory diseases. In August 2019, RINVOQ received U.S. Food and Drug Administration approval for adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. In December 2019, RINVOQ also received approval by the European Commission for the treatment of adult patients with moderate to severe active rheumatoid arthritis who have responded inadequately to, or who are intolerant to one or more disease-modifying anti-rheumatic drugs. Phase 3 trials of RINVOQ in rheumatoid arthritis, psoriatic arthritis, axial spondyloarthritis, Crohn's disease, atopic dermatitis, ulcerative colitis and giant cell arteritis are ongoing.

The Scottish Funding Council said this week that a country-wide precision medicine initiative in Scotland has received up to £9.5 million ($12.3 million) in new funding. The funding includes £7.5 million from the council and up to £2 million from Scottish Enterprise, and will support the growth of precision medicine in Scotland managed by the Precision Medicine Scotland Innovation Centre (formerly the Stratified Medicine Scotland Innovation Centre). The newly launched phase 2 of the center will continue to act as a catalyst for partnerships between industry, academia, and clinical entities. In phase 1 the Innovation Centre produced several large-scale projects in areas including ovarian cancer, rheumatoid arthritis, esophageal cancer, and multiple sclerosis. The center said it expects to be able to attract around £4.2 million in income from other sources.

See also

Discover Eckher Semantic Web Browser: "http://xmlns.com/foaf/0.1/Person", "http://schema.org/Organization", "http://www.w3.org/2004/02/skos/core#definition", "http://www.wikidata.org/entity/Q1".

Discover English pronunciations: "Macedonia", "mystique", "myosin", "myopathy", "Myomorpha", "myoclonus", "azole", "Ursula von der Leyen", "bureaux", "Yvonne".

Create sequence logos for protein and DNA/RNA alignments using Eckher Sequence Logo Maker.

Compose speech audio from IPA phonetic transcriptions using Eckher IPA to Speech.

Browse place name pronunciation on Eckher IPA Map.

Enter IPA characters using Eckher IPA Keyboard.

Navigate the Semantic Web and retrieve the structured data about entities published on the web using Eckher Semantic Web Browser.

Turn your phone into a compass using Eckher Compass.

Browse word pronunciations online using Eckher Dictionary.

Author, enrich, and query structured data using Eckher Database for RDF.

Create TeX-style mathematical formulas online with Eckher Math Editor.

Create knowledge graphs using Eckher RDF Graph Editor.

Send messages and make P2P calls using Eckher Messenger.

Build event-sourced systems using Eckher Database for Event Sourcing.

View PDB files online using Eckher Mol Viewer.

Listen to your text using Eckher Text to Speech.

View FASTA sequence alignments online with Eckher Sequence Alignment Viewer.

Convert Punycode-encoded internationalized domain names (IDNs) to Unicode and back with Eckher Punycode Converter.

Explore the human genome online with Eckher Genome Browser.

Edit text files online with Eckher Simple Text Editor.

Send test emails with Eckher SMTP Testing Tool.

Разбор слов по составу: "уборка", "хлебный", "украсить", "принести", "говорливый", "заколка", "безветренный", "земляной", "надрезать", "приберечь", "сероватый", "ракетчик", "домик", "вывозить", "безлюдный", "кожаный", "беспосадочный", "шахматистка", "слышать", "бескрайний", "удалец", "прошуметь", "посадка", "приехать".